Patient adherence to fecal calprotectin testing is low compared to other commonly ordered tests in patients with inflammatory bowel disease

Nidah S. Khakoo, Ayanna Lewis, Giovanni A. Roldan, Alex Al Khoury, Maria A. Quintero, Amar R. Deshpande, David H. Kerman, Oriana M. Damas, Maria T. Abreu

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Limited data exist on adherence to fecal calprotectin (FCP) testing in patients with inflammatory bowel disease. Methods: Completion rates for patients who had at least one FCP test ordered (n = 3082) and a subgroup with C-reactive protein, complete blood count, and Clostridium difficile tests also ordered (n = 1563) were analyzed. Results: More patients completed blood than stool tests, with FCP having the poorest adherence of all tests analyzed. Older patients had higher FCP completion rates. No differences were noted in completion rates across age, gender, or ethnicity for blood tests. Conclusions: Further studies are needed to develop strategies that improve the uptake of FCP.

Original languageEnglish (US)
Article numberotab028
JournalCrohn's and Colitis 360
Volume3
Issue number3
DOIs
StatePublished - Jul 1 2021

Keywords

  • Biomarkers
  • Calprotectin
  • Crohn's disease
  • Inflammatory bowel disease
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'Patient adherence to fecal calprotectin testing is low compared to other commonly ordered tests in patients with inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this